Take Control of Your Drinking?
A Phase 2, Double-Blind, Randomized, Placebo Controlled Trial to Assess the Efficacy of ABT-436 for Alcohol Dependence
Psychiatry and Neurobehavioral Sciences
A clinical trial of an investigational medication for the treatment of alcohol problems are being conducted at UVA’s Center for Addiction Research and Education. This study is open to women and men between 21 and 65. No insurance is needed. Participation is confidential. Compensation for time and travel is up to $595 for the completed study. UVA C.A.R.E. | Charlottesville 434-243-0541 or 888-882-2345 (toll-free) email@example.com IRB-HSR # 16560 Principal Investigator: Bankole Johnson, M.D.
Compensation for time and travel is up to $595 for the completed study.